Forskolin modifies retinal vascular development in Mrp4- Knockout mice

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 8029-8035

  Matsumiya, Wataru ^a   Kusuhara, Sentaro ^a   Hayashibe, Keiko ^a   Maruyama, Kazuichi ^b   Kusuhara, Hiroyuki ^c   Tagami, Mizuki ^a   Schuetz, John D ^d   Negi, Akira ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; FORSKOLIN; KI 67 ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 4;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPEROXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETINA BLOOD VESSEL;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; CYCLIC AMP; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FORSKOLIN; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OXYGEN; RETINAL VESSELS; RETINOPATHY OF PREMATURITY;

EID: 84873388563     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10781     Document Type: Article

References (22)

1. Borst P, de Wolf C, van de Wetering K. Multidrug resistanceassociated proteins 3, 4, and 5. Pflügers Arch. 2007;453:661-673.
2. Ritter CA, Jedlitschky G, Meyer zu Schwabedissen H, Grube M, Kock K, Kroemer HK. Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev. 2005;37:253-278.
3. Russel FG, Koenderink JB, Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci. 2008; 29:200-207.
4. Ose A, Ito M, Kusuhara H, et al. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). Drug Metab Dispos. 2009;37:315-321.
5. Sassi Y, Abi-Gerges A, Fauconnier J, et al. Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes. FASEB J. 2012;26:1009-1017.
6. Sassi Y, Lipskaia L, Vandecasteele G, et al. Multidrug resistanceassociated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. J Clin Invest. 2008;118:2747-2757.
7. Hara Y, Sassi Y, Guibert C, et al. Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice. J Clin Invest. 2011;121:2888-2897.
8. Bir SC, Xiong Y, Kevil CG, Luo J. Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases. Cardiovasc Res. 2012;95:7-18.
9. Tachikawa M, Toki H, Tomi M, Hosoya K. Gene expression profiles of ATP-binding cassette transporter A and C subfamilies in mouse retinal vascular endothelial cells. Microvasc Res. 2008;75:68-72.
10. Tagami M, Kusuhara S, Honda S, Tsukahara Y, Negi A. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygeninduced retinopathy. Brain Res. 2009;1283:186-193.
11. Tagami M, Kusuhara S, Imai H, et al. MRP4 knockdown enhances migration, suppresses apoptosis, and produces aggregated morphology in human retinal vascular endothelial cells. Biochem Biophys Res Commun. 2010;400:593-598.
12. Leggas M, Adachi M, Scheffer GL, et al. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol. 2004;24:7612-7621.
13. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
14. Stahl A, Connor KM, Sapieha P, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51: 2813-2826.
15. Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol. 2003;163:1801-1815.
16. Kamiyama M, Pozzi A, Yang L, DeBusk LM, Breyer RM, Lin PC. EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene. 2006;25:7019-7028.
17. Rao R, Redha R, Macias-Perez I, et al. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J Biol Chem. 2007;282:16959-16968.
18. Yanni SE, Barnett JM, Clark ML, Penn JS. The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Invest Ophthalmol Vis Sci. 2009;50:5479-5486.
19. Copsel S, Garcia C, Diez F, et al. Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem. 2011;286:6979-6988.
20. Fisslthaler B, Fleming I. Activation and signaling by the AMPactivated protein kinase in endothelial cells. Circ Res. 2009; 105:114-127.
21. Torella D, Gasparri C, Ellison GM, et al. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K. Am J Physiol Heart Circ Physiol. 2009;297:H2015-H2025.
22. Yamamizu K, Yamashita JK. Roles of cyclic adenosine monophosphate signaling in endothelial cell differentiation and arterial-venous specification during vascular development. Circ J. 2011;75:253-260.